Literature DB >> 17394205

Expression pattern of Vasohibin during chick development.

Suresh Nimmagadda1, Poongodi Geetha-Loganathan, Felicitas Pröls, Martin Scaal, Bodo Christ, Ruijin Huang.   

Abstract

Vasohibin is an angiogenesis inhibitor that is induced in endothelial cells in an autocrine manner. In this study, we cloned a 500-bp fragment of chick Vasohibin cDNA and analyzed its expression pattern by in situ hybridization during chick development. From HH-stage 3, expression of Vasohibin is observed in the area opaca and it is expressed throughout the primitive streak during later stages. At HH-stage 11, Vasohibin is expressed in head paraxial mesoderm, in the vitelline vein, dorsal neural tube, intermediate and lateral plate mesoderm, Wolffian duct, and blood islands at the caudal part of the embryo. In epithelial somites, expression is seen in the region around the somitocoel, and after somite maturation, expression is observed in the myotome, which becomes stronger with development. Expression is detected in fore and hind brain, also in the retina and lens vesicle of the developing eye. In the early limb bud, expression is initiated in the mesenchyme and becomes stronger during later stages. Expression in the limb mesoderm remains strong at the margins but decreases in the central mesenchyme. At day 7, expression is seen in interdigital grooves of the digits and digit-demarcating regions. During organogenesis, expression is seen in the anlagen of the esophagus, trachea, duodenum, lungs, liver, heart, and gut. Our analysis shows that Vasohibin is expressed in a wide range of tissues and organs suggesting that Vasohibin acts as a physiological regulator of vascular development during chick embryogenesis. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17394205     DOI: 10.1002/dvdy.21134

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  5 in total

Review 1.  The vasohibin family: a novel family for angiogenesis regulation.

Authors:  Yasufumi Sato
Journal:  J Biochem       Date:  2012-10-25       Impact factor: 3.387

2.  Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.

Authors:  Guangning Zhao; Yuming Yang; Yang Tang; Ruifa Han; Yan Sun
Journal:  Med Oncol       Date:  2012-08-03       Impact factor: 3.064

Review 3.  The Vasohibin Family.

Authors:  Yasufumi Sato
Journal:  Pharmaceuticals (Basel)       Date:  2010-02-05

4.  Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.

Authors:  Johann Kern; Michael Steurer; Günther Gastl; Eberhard Gunsilius; Gerold Untergasser
Journal:  BMC Cancer       Date:  2009-08-17       Impact factor: 4.430

Review 5.  The roles of vasohibin and its family members: Beyond angiogenesis modulators.

Authors:  Hua Du; Jing Zhao; Ling Hai; Jing Wu; Hua Yi; Yonghong Shi
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.